PTKF.Y Stock Overview
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
PT Kalbe Farma Tbk. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp21.05 |
| 52 Week High | Rp29.10 |
| 52 Week Low | Rp21.05 |
| Beta | 0.19 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -27.34% |
| 3 Year Change | 2.28% |
| 5 Year Change | -0.80% |
| Change since IPO | 13.67% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| PTKF.Y | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | 0.3% |
| 1Y | -27.3% | 15.8% | 26.2% |
Return vs Industry: PTKF.Y underperformed the US Pharmaceuticals industry which returned 22.5% over the past year.
Return vs Market: PTKF.Y underperformed the US Market which returned 26.3% over the past year.
Price Volatility
| PTKF.Y volatility | |
|---|---|
| PTKF.Y Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PTKF.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PTKF.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1966 | 13,134 | - Vidjongtius | https://www.kalbe.co.id |
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals and Distribution; and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products.
PT Kalbe Farma Tbk. Fundamentals Summary
| PTKF.Y fundamental statistics | |
|---|---|
| Market cap | US$4.30b |
| Earnings (TTM) | US$186.81m |
| Revenue (TTM) | US$1.91b |
23.0x
P/E Ratio2.3x
P/S RatioIs PTKF.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PTKF.Y income statement (TTM) | |
|---|---|
| Revenue | Rp30.31t |
| Cost of Revenue | Rp18.70t |
| Gross Profit | Rp11.61t |
| Other Expenses | Rp8.65t |
| Earnings | Rp2.96t |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 64.03 |
| Gross Margin | 38.31% |
| Net Profit Margin | 9.77% |
| Debt/Equity Ratio | 4.7% |
How did PTKF.Y perform over the long term?
See historical performance and comparison